Clinical trials
Carcinoma, Non-Small-Cell Lung trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
645 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 3 |
| 2002 | 4 |
| 2003 | 2 |
| 2004 | 9 |
| 2005 | 9 |
| 2006 | 19 |
| 2007 | 14 |
| 2008 | 21 |
| 2009 | 18 |
| 2010 | 13 |
| 2011 | 17 |
| 2012 | 18 |
| 2013 | 21 |
| 2014 | 19 |
| 2015 | 37 |
| 2016 | 25 |
| 2017 | 28 |
| 2018 | 25 |
| 2019 | 37 |
| 2020 | 37 |
| 2021 | 40 |
| 2022 | 46 |
| 2023 | 42 |
| 2024 | 50 |
| 2025 | 48 |
| 2026 | 23 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 254 |
| Recruiting | 121 |
| Active, not recruiting | 118 |
| Terminated | 91 |
| Unknown status | 45 |
| Not yet recruiting | 9 |
| Withdrawn | 3 |
| Available | 2 |
| Enrolling by invitation | 1 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 46 |
| Novartis Pharmaceuticals | 44 |
| Eli Lilly and Company | 41 |
| Hoffmann-La Roche | 41 |
| Bristol-Myers Squibb | 32 |
| Pfizer | 29 |
| Merck Sharp & Dohme LLC | 28 |
| GlaxoSmithKline | 15 |
| Boehringer Ingelheim | 13 |
| ETOP IBCSG Partners Foundation | 12 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 645 |
| Lung Neoplasms | 122 |
| Neoplasms | 57 |
| Melanoma | 40 |
| Neoplasm Metastasis | 39 |
| Colorectal Neoplasms | 37 |
| Breast Neoplasms | 26 |
| Triple Negative Breast Neoplasms | 24 |
| Carcinoma, Renal Cell | 21 |
| Ovarian Neoplasms | 21 |
Trials
Showing 1 to 25 of 645. Each trial links to its page on Pharma Observatory.
545 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.